HUKUI sincerely invites you to join us in BIO Asia-Taiwan 2024. At this show, we will present our products and innovative solutions. It would be a great pleasure to meet you at the exhibition! Welcome to our Booth # L421
The 40Hz audiovisual stimulation therapy for Alzheimer‘s disease was proposed by the research team from the Department of Brain and Cognitive Sciences at the Massachusetts Institute of Technology (MIT). In December 2016, this research team published a study titled “Gamma frequency entrainment attenuates amyloid load and modifies microglia” in the journal “Nature.” This study revealed that “40Hz flickering light” can…
Hukui sincerely invites you to join us in MD&M WEST 2024. At this show, we will present our core products and innovative solutions. It would be a great pleasure to meet you at the exhibition!
On December 13th, HUKUI Biotechnology Co., Ltd. (referred to as HUKUI) celebrated its 10th anniversary at the Courtyard by Marriott Taipei. The event brought together renowned enterprises, suppliers, and partners from various industries such as finance, manufacturing, and healthcare to commemorate this remarkable milestone.
HUKUI Biotechnology Co., Ltd. (referred to as HUKUI), in collaboration with the global semiconductor leader Infineon, is developing a health smart ring and strategically entering the smart health monitoring wearable market.
HUKUI Biotechnology Co., Ltd. (referred to as HUKUI), a leading global medical electronics manufacturing service provider, has formally partnered with the Silicon Valley-based smart wearable equipment company, EyeZense Inc., in a strategic development collaboration. This partnership leverages HUKUI’s expertise in miniature endoscopic lenses to jointly design and manufacture intelligent security wearable camera devices. In alignment with industry trends, they will…
Founded by the Chairman John Hsuan 8 years ago, HKBio has spent years honing the expertise in regulatory consultation, product registration services, and contract design and development services for medical device products. HKBio has announced this month that it has partnered with Brain Navi Biotechnology to co-develop a robot-assisted brain endoscope, helping surgeons safely, swiftly and accurately to place endoscopes…
As the COVID-19 outbreak has spread in the past 2 years, the global healthcare providers have been experiencing severe operational and clinical challenges, including routine appointment and surgery cancellations, cross infections between patients and caregivers, and hospital staff shortage. This had a great impact on the utilization and procurement of diagnostic devices and surgical instruments.
Established by the Chairman, John Hsuan, 8 years ago, HKBio has delved into the regulatory services and contract design and manufacturing services for almost a decade. In 2021, HKBio had a record-breaking year due to the rapid growth in Taiwanese corporate rapid testing needs and sales growth in China, achieving more than 6 fold annual revenue growth and quarterly break-even…
Medical device design and development are highly technical and specialized. It is even more challenging for an early stage medical device startup to have the necessary resources to build an end-to-end manufacturing facility, from small scale prototypes to large scale mass production, not to mention the cost of clinical trial and patent maintenance. This is exactly the reason why medical…
A few decades ago, medical device OEMs single-handedly developed and manufactured their medical innovations. The advantage of this kind of operation is the ability to have complete control over design and development, small pilot production, and large scale mass production. However, a large-scale ISO13485 compliant GMP manufacturing facility represents an enormous capital commitment.
The medtech service provider Hukui Bio (互貴興業) announced that it has raised US$5.5 million in Series C funding, led by Yellowstone Holding AG from Switzerland, totalling US$11.8M funding to date. HuKui Bio will collaborate with venture capital funds in the Bay area, in addition to the biomedical innovation clusters and accelerators in Europe and the US. The New Business Department…
In 2020, the epidemic of COVID-19 has spread in the whole world, and COVID-19 diagnostic kit is definitely a purchasing point from the beginning. Hukui Bio has been authorized bytwo Taiwan nucleic acid diagnostic kit factories to begin providing COVID-19 diagnostic kit for Europe, ASEAN and South America markets, hoping to satisfy their local medical resources.
“Blood Leakage Detection System”, developed by AcuSense BioMedical Technology Corp. (AcuSense), is a specific medical device designed for kidney disease patient to reduce the risk of dialysis treatment. Through the cooperation with HUKUI Tech, the subsidy of Hukui Biotechnology Co., Ltd., AcuSense is going to expand its business to China. HUKUI Tech integrates product authorization, registration, production and distribution as…
In 2020, the epidemic of COVID-19 has spread in the whole world, and COVID-19 diagnostic kit is definitely a purchasing point from the beginning. HUKUI Bio has been authorized by two Taiwan nucleic acid diagnostic kit factories to begin providing COVID-19 diagnostic kit for Europe, ASEAN and South America markets, hoping to satisfy their local medical resources.
What are the central authorities in charge of medical devices in various countries? United States Food and Drug Administration (FDA) Attached to United States Department of Health, Education, and Welfare, is in charge of the administration of drugs, food, biological products, cosmetics, veterinary drugs, medical devices and diagnostic supplies throughout the country. Taiwan Taiwan Food…
Are clinical trials necessary for medical devices to enter China? According to the 2018 announcement on the latest “Catalogue of medical devices exempted from clinical trials” (No. 94, 2018) and “Catalogue of IVD reagents exempted from clinical trials”, when the product description conforms to the medical devices or IVD reagents of the specification on the…
What are the norms for setting up a medical device factory in China? Good Manufacturing Practice for Medical Devices and YY0287-2017-Medical Devices-Quality Management Systems-Requirements for regulatory purposes / ISO 13485:2016 need to be followed. What is the current situation of centralized procurement of medical consumables? In March 2018, China changed the National Health and Family…
What are innovative medical devices? The core technology of the product has Chinese patent right for invention, or the application for invention patent has been reported to the Patent Administration Department under the State Council of China. The main working principle or action mechanism of the product is the first in China, and the product…
HuKui Biotechnology Co., Ltd.(HUKUI Bio) announced that its wholly-owned subsidiary HuKui Technology Co., Ltd.(HUKUI Tech), has officially acquired the Class II Medical Device Registration License from Chongqing Municipal Drug Administration in China for two products: blood glucose test strip and uric acid test strip, on January 8th. It is the first time a manufacturer obtaining…
The Hukui Biotechnology (Chongqing) Corporation, the subsidiary of Hukui Biotechnology Corporation, signed the Cooperation Framework Agreement with the Zhongguancun Medical Engineering Transformation (Chongqing) Center to promote the development of the biotechnology industry. The goal of the Agreement is to create a biotech incubator platform that promotes the smart medical industry focusing on the development of medicine, top-of-the-range medical equipment, testing…
Taipei, Taiwan, June 13, 2017 General Life Biotechnology Co., Ltd., an affiliate of Compal Group (TWSE:2324), has signed a contract with Hukui Biotechnology Corporation. General Life Biotechnology Co., Ltd. will provide the key components and technical support, and Hukui Technology, the Chongqing-based subsidiary of Hukui Biotechnology Corporation is then responsible to apply for the license…
The Taiwan Carbon Nanotube Technology Corporation (TCNT) announced Wednesday (2017/03/29) that it has inked a BMS(Biotech Manufacturing Services) contract and marketing memorandum of understanding (MOU) with HuKui.
Taiwan’s high-tech guru John Hsuan (宣明智) aims for significant growth in mainland China’s market in order to make the biotech industry the next pride of Taiwan.
By John Liu, The China Post August 16, 2016, 12:30 am TWN The China PostTaiwan’s high-tech guru John Hsuan (宣明智) aims for significant growth in mainland China’s market in order to make the biotech industry the next pride of Taiwan. The honorary vice chairman of the United Microelectronics Corp (UMC, 聯電), one of Taiwan’s leading high-tech companies, has high expectations…